Atlas Trials

Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus

Clinical trial NCT05934903 · TERMINATED

Trial details

NCT number
NCT05934903
Sponsor
Yale University
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Status EpilepticusRefractory Status Epilepticus
Start date
2023-08-31
Primary completion
2025-03-31
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.